Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Horizon Technology F (HRZN)

Horizon Technology F (HRZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Horizon Technology Finance: Q1 Earnings Snapshot AP - Tue Apr 30, 3:38PM CDT

Horizon Technology Finance: Q1 Earnings Snapshot

HRZN : 11.75 (-0.25%)
Here Are My Top 3 Ultra-High-Yield Dividend Stocks to Buy in April Motley Fool - Sat Apr 13, 6:00AM CDT

Investors looking for some reliable growth may want to consider three ultra-high-yield business development companies.

COMP : 3.26 (-4.12%)
HTGC : 19.75 (-0.05%)
HRZN : 11.75 (-0.25%)
ARCC : 20.86 (+0.29%)
Investing $50,000 Into These Ultra-High-Yield Dividend Stocks Could Make You Nearly $5,200 in Annual Income Motley Fool - Sun Mar 17, 5:50AM CDT

Business development companies (BDCs) can be a lucrative source of passive income because of their unique business structure.

HTGC : 19.75 (-0.05%)
HRZN : 11.75 (-0.25%)
ARCC : 20.86 (+0.29%)
Here Are My Top 10 Ultra-High-Yield Dividend Stocks to Buy in 2024 Motley Fool - Wed Mar 6, 4:30AM CST

These 10 companies offer exposure to many different sectors, while providing steady passive income.

BRK.AX : 0.013 (-7.14%)
T : 17.15 (+0.41%)
NLY : 19.75 (+0.56%)
D : 51.96 (-0.31%)
ABR : 13.41 (-0.37%)
SPY : 517.22 (+0.02%)
VOO : 475.40 (-0.04%)
RSP : 164.45 (-0.03%)
TMUS : 163.28 (+0.67%)
CMCSA : 39.47 (+2.55%)
AGNC : 9.55 (+0.32%)
HTGC : 19.75 (-0.05%)
Horizon Technology Finance: Q4 Earnings Snapshot AP - Tue Feb 27, 3:43PM CST

Horizon Technology Finance: Q4 Earnings Snapshot

HRZN : 11.75 (-0.25%)
Want to Make $10,000 in Passive Income This Year? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks. Motley Fool - Tue Feb 27, 5:45AM CST

Business development companies (BDCs) can be lucrative opportunities for investors seeking dividend income.

HTGC : 19.75 (-0.05%)
HRZN : 11.75 (-0.25%)
ARCC : 20.86 (+0.29%)
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC. Newswire.ca - Wed Feb 21, 12:54PM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the acquisition of the...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0587 (-2.17%)
HRZN : 11.75 (-0.25%)
Stocks in play: Biovaxys Technology Corp Baystreet - Mon Feb 12, 1:32PM CST

Announced it has executed the definitive Asset Purchase Agreement dated February 11th, 2024 to acquire ...

HRZN : 11.75 (-0.25%)
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc. Newswire.ca - Mon Feb 12, 1:17PM CST

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive Asset Purchase...

BIOV.CN : 0.0800 (+14.29%)
BVAXF : 0.0587 (-2.17%)
HRZN : 11.75 (-0.25%)
Investing $100,000 in These 3 Ultra-High-Yield Dividend Stocks Could Bring $10,000 in Passive Income to Your Portfolio in 2024 Motley Fool - Fri Jan 5, 5:30AM CST

Business development companies are a lucrative way to generate loads of passive income.

BRK.AX : 0.013 (-7.14%)
HTGC : 19.75 (-0.05%)
HRZN : 11.75 (-0.25%)
ARCC : 20.86 (+0.29%)

Barchart Exclusives

Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results Barchart - 1 hour ago
Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart report. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot